Back to search

Peptide record

TPDB41260

TAT-2D5 Anticancer standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41260
TAT-2D5
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 21-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
GRKKRRQRRRPPQGGLTIYFY
Physicochemical Analysis
C117H193N43O27
ANDCEHMSWV
R
2634.09
12.41
8
0
5
+8
5.19
-1.829
37.14
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
2980
113.13
5
Residue Composition
number
0
A
6
R
0
N
0
D
0
C
0
E
2
Q
3
G
0
H
1
I
1
L
2
K
0
M
1
F
2
P
0
S
1
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 0 R: 6 N: 0 D: 0 C: 0 E: 0 Q: 2 G: 3 H: 0 I: 1 L: 1 K: 2 M: 0 F: 1 P: 2 S: 0 T: 1 W: 0 Y: 2 V: 0
Chemical Descriptors
21
C117H193N43O27
2634.09
12.41
+8
5.19
-1.829
Free
L
Linear
Free
Anticancer
STAP-2 PH domain–derived peptide
Evidence Records 1 records
Evidence 1 Activity

Activity

Graph figure 1-G
Anticancer

Target

Liver Cancer
DU-145
Liver

Assay & Model

CellTiter-Glo assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.